Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
Oxford University Press
2016
|